156 related articles for article (PubMed ID: 17030856)
1. Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.
Narayan R; Buronfosse T; Schultz U; Chevallier-Gueyron P; Guerret S; Chevallier M; Saade F; Ndeboko B; Trepo C; Zoulim F; Cova L
J Gen Virol; 2006 Nov; 87(Pt 11):3225-3232. PubMed ID: 17030856
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection.
Long JE; Huang LN; Qin ZQ; Wang WY; Qu D
World J Gastroenterol; 2005 Aug; 11(32):4967-73. PubMed ID: 16124047
[TBL] [Abstract][Full Text] [Related]
3. In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.
Saade F; Buronfosse T; Guerret S; Pradat P; Chevallier M; Zoulim F; Jamard C; Cova L
J Viral Hepat; 2013 Apr; 20(4):e56-65. PubMed ID: 23490390
[TBL] [Abstract][Full Text] [Related]
4. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
5. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection.
Thermet A; Buronfosse T; Werle-Lapostolle B; Chevallier M; Pradat P; Trepo C; Zoulim F; Cova L
J Gen Virol; 2008 May; 89(Pt 5):1192-1201. PubMed ID: 18420797
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the kinetics of the specific cellular immune response to duck hepatitis B virus in infected and immune ducks.
Vickery K; Cossart Y; Dixon R
Vet Microbiol; 1999 Aug; 68(1-2):157-69. PubMed ID: 10501173
[TBL] [Abstract][Full Text] [Related]
10. The effect of surgical immunomodulation on liver inflammation and clearance of DHBV infection.
Vickery K; Tohidi-Esfahani R; Pouliopoulos J; Welschinger R; Dixon R; Deva A; Cossart Y
J Med Virol; 2006 Dec; 78(12):1572-8. PubMed ID: 17063509
[TBL] [Abstract][Full Text] [Related]
11. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
12. Duck hepatitis B virus (DHBV) infection in Indian domestic ducks: a pilot study.
Sridhar G; Valliammai T; Varalakshmi CS; Udayasankar K; Panchanadam M; Ramakrishna J; Gopal KV; Jayaraman K; Thyagarajan SP
Trop Anim Health Prod; 1993 Nov; 25(4):229-33. PubMed ID: 8109057
[TBL] [Abstract][Full Text] [Related]
13. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
[TBL] [Abstract][Full Text] [Related]
14. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
[TBL] [Abstract][Full Text] [Related]
15. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes.
Schultz U; Chisari FV
J Virol; 1999 Apr; 73(4):3162-8. PubMed ID: 10074168
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of duck hepatitis B virus isolates from South African ducks.
Mangisa NP; Smuts HE; Kramvis A; Linley CW; Skelton M; Tucker TJ; De La M Hall P; Kahn D; Jilbert AR; Kew MC
Virus Genes; 2004 Mar; 28(2):179-86. PubMed ID: 14976417
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B virus activity of α-DDB-FNCG, a novel nucleoside-biphenyldicarboxylate compound in vitro and in vivo.
Yang Q; Zhao X; Yu W; He W; Fang X; Zang L; Wan N; Wang Q; Zheng L; Chang J
J Pharmacol Sci; 2014; 126(3):208-15. PubMed ID: 25409748
[TBL] [Abstract][Full Text] [Related]
19. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.
Cheung RC; Trujillo DE; Robinson WS; Greenberg HB; Marion PL
Virology; 1990 Jun; 176(2):546-52. PubMed ID: 1693247
[TBL] [Abstract][Full Text] [Related]
20. A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus.
Meier P; Scougall CA; Will H; Burrell CJ; Jilbert AR
Virology; 2003 Dec; 317(2):291-8. PubMed ID: 14698667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
